ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Expression of Injury and Repair Genes in Ex Vivo Perfused Swing Lung Transplants.

    P. Dromparis,1 S. Wagner,1 N. Aboelnaz,2 J. Luc,2 D. Freed,2 J. Nagendran,2 M. Mengel,1 B. Adam.1

    1Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada; 2Surgery (Cardiac Surgery), University of Alberta, Edmonton, Canada

    Due to acute lung injury (ALI), only 20% of donated lungs are suitable for transplant and of those, 25% develop primary graft dysfunction. Ex vivo…
  • 2017 American Transplant Congress

    Hepatitis E Virus-Associated Cryoglobulinemia in Solid-Organ-Transplant Recipients: A Prospective Study.

    O. Marion,1 F. Abravanel,2 L. Esposito,1 S. Lhomme,2 A. Del Bello,1 J. Izopet,2 N. Kamar.1

    1Nephrology and Organ Transplant Unit, CHU Rangueil, Toulouse, France; 2Laboratory of Virology, CHU Purpan, Toulouse, France

    Hepatitis E virus (HEV) is responsible for acute and chronic autochthonous hepatitis in developed countries, particularly in Western Europe. Conversely to hepatitis B or C,…
  • 2017 American Transplant Congress

    Factors Predicting 30-Day Hospital Readmission After Kidney Transplant.

    J. Ostrem, M. Brokhof, N. Kenyon, E. Hollinger, S. Jensik, O. Olaitan, M. Hertl, N. Alvey.

    Rush University Medical Center, Chicago, IL

    Background: Hospital readmissions after kidney transplant have been associated with increased morbidity, mortality, decreased quality of life, and increased healthcare costs. The objective of this…
  • 2017 American Transplant Congress

    The Use of Very High KDPI Kidneys in Elderly Kidney Transplant Recipients – Discarded in the U.S. but Successfully Transplanted in Europe.

    F. Halleck, D. Khadzhynov, G. Rehse, L. Lehner, E. Schrezenmeier, M. Dürr, K. Budde, O. Staeck.

    Nephrology, Charité Berlin, Berlin, Germany

    Background: Very limited data exist on long-term outcomes of very high KDPI kidneys in elderly (≥65 years) kidney transplant recipients (KTR). Discard rates of donor…
  • 2017 American Transplant Congress

    Improved Outcomes After Liver Transplantation from Controlled DCD Donors with Normothermic Regional Perfusion.

    G. Oniscu, F. Hunt, W. Herries, I. Currie, A. Sutherland, C. Beattie, E. Thomson.

    Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

    Background: Normothermic regional perfusion (NRP) is currently explored as a method to recover organs from Maastricht category I-III Donors after circulatory death (DCD). This study…
  • 2017 American Transplant Congress

    Belatacept for Chronic Antibody-Mediated Rejection in Kidney Transplantation.

    D. Kumar,1 G. Gupta,1 J. Reeve,2 P. Sanghi,1 S. Bobba,1 M. Levy,1 C. Bhati,1 P. Kimball,1 H. Fattah,1 A. King,1 H. Massey,1 P. Halloran.2

    1Virginia Commonwealth University, Richmond; 2Alberta Transplant Applied Genomics Center, Edmonton, Canada

    Background: Chronic antibody mediated rejection (cAMR) is a major cause of long-term kidney transplant (KT) loss. Antibody or immune cell depletional therapies have unclear efficacy…
  • 2017 American Transplant Congress

    Macrophage Specific Deletion of RhoA Inhibits Fractalkine Signaling and Abrogates Chronic Rejection of Cardiac Allograft.

    M. Kloc, Y. Liu, W. Chen, X. Li, R. Ghobrial.

    Surgery, Houston Methodist Hospital and Research Institute, Houston

    Objective. Chronic rejection of transplanted organs remains unresolved issue in organ transplantation. The chronic rejection is the most common cause of graft loss within 10…
  • 2017 American Transplant Congress

    Donor Warm Ischemic Time >80min Is an Important Predictor of Kidney Graft Survival from Donors After Cardiac Death.

    J. Chen,1 D. Mikhail,2 H. Sharma,3 A. Hijazi,1 D. Nap,1 L. Stitt,4 J. Jevnikar,5 M. Cooper,6 P. Luke,2 A. Sener.2

    1Schulich School of Medicine & Dentistry, London, Canada; 2Urology, Western University, London, Canada; 3General Surgery, Western University, London, Canada; 4LW Stitt Statistical Services, London, Canada; 5Engineering, Ryerson University, Toronto, Canada; 6Georgetown University, Washington

    We analyzed UNOS data to determine how donor warm ischemic time (WIT), donor BMI, donor hypertension (dHTN), cold ischemic time (CIT), and vasopressin use in…
  • 2017 American Transplant Congress

    High Mortality in Transplant Recipients Associated with Coccidioidomycosis Derived from Organ Donors.

    N. Jeyakumar,2 N. Neidlinger,3 M. Salvatore,3 C. Brown,4 T. Carpenter,3 M. Fung,1 P. Chin-Hong.1

    1Department of Medicine, University of California, San Francisco, San Francisco, CA; 2Department of Medicine, University of Miami Miller School of Medicine, Miami, FL; 3Donor Network West, San Ramon, CA; 4Decision Patterns, Oakland, CA

    Purpose Coccidioidomycosis (CI) occurs in 4-9% of solid organ recipients in endemic areas, resulting in 30-63% mortality. CI can be transmitted directly via transplantation, but…
  • 2017 American Transplant Congress

    Outcomes of Infrainguinal Revascularization in Renal Transplant Patients.

    R. Craig-Schapiro, B. Nejim, M. Malas.

    Department of Surgery, Johns Hopkins Medical Institutes, Baltimore, MD

    Objective: While there have been a number of studies suggesting poor outcomes of lower extremity revascularization in patients with end-stage renal disease (ESRD), little is…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences